Evidence map›Paper›PMID 39247877›Full record

ArticleJournal of Alzheimer's disease reports2024

The Association Between Brain Metabolic Biomarkers Using

Min Xiong, Hongji You, Wang Liao, Yingren Mai, Xiaoming Luo, Yipei Liu, Sheng-Nan Jiang

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Neurotransmitter Systems in Alzheimer's Disease.Current issues in molecular biology · 2026
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Min XiongDepartment of Nuclear Medicine, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Hongji YouDepartment of Nuclear Medicine, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Wang LiaoDepartment of Neurology, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Yingren MaiDepartment of Neurology, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Xiaoming LuoDepartment of Nuclear Medicine, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Yipei LiuDepartment of Nuclear Medicine, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Sheng-Nan JiangDepartment of Nuclear Medicine, the Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Objective: To explore the effectiveness of Methods: 107 participates including 19 mild cognitive impairment (MCI), 38 mild AD, 24 moderate AD, 15 moderate-severe AD, and 11 frontotemporal dementia (FTD) were enrolled. Visual and voxel-based analysis procedures were utilized. Cognitive conditions, including 6 cognitive function scores and 7 single-domain cognitive performances, and vascular risk factors linked to hypertension, hyperlipidemia, diabetes, and obesity were correlated with glucose metabolism in AD dementia using age as a covariate. Results: Conclusions: This study underlines the vital role of

Indexed as

18FluorodeoxyglucoseAlzheimer’s diseasecognitive functionmetabolismmild cognitive impairmentpositron emission tomographyrisk factor

Identifiers

PMID39247877
PMCPMC11380275

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.